Navigation Links
NHS Human Services to Merge With Allegheny Valley School
Date:2/19/2008

LAFAYETTE HILL, Pa., Feb. 19 /PRNewswire-USNewswire/ -- NHS Human Services, one of Pennsylvania's largest not-for-profit providers of human services headquartered in Lafayette Hill, PA, and Allegheny Valley School (AVS) located in Allegheny County, signed an agreement to merge their services. NHS will provide management support and AVS will continue to operate as they have for the last 48 years.

NHS, which was one of the original base service units in Philadelphia, now provides care to over 50,000 individuals a year in five states. They provide services in the areas of behavioral health, intellectual/developmental disabilities (IDD), addictive diseases, autism, juvenile justice, elder care and foster care. This merger will make NHS one of the country's largest non-profit providers.

Allegheny Valley School, with programs in 9 Pennsylvania counties, provides outstanding community residential services and therapeutic programs to children and adults with intellectual and developmental disabilities. Many of the individuals served by AVS also have multiple physical handicaps, medical complications and behavioral management needs. They currently serve 900 consumers between the ages of 10 and 90 at 126 facilities.

Patricia Miller Duggan, Board Chairperson of AVS, stated, "NHS offers the best of quality clinical ability combined with cutting edge technology and access to capital which will allow AVS to secure our historic mission long into the future."

NHS Chairman and CEO, the Honorable M. Joseph Rocks commented, "this transaction with AVS, one of the most significant providers of care to individuals with IDD, will be one of the largest non-profit mergers affecting this vulnerable population. We share the same keen sense of mission and commitment to quality of life issues for the people in our care. Our combined staffs represent the best of clinical talent and technology. This combined expertise will enhance our ability to provide
'/>"/>

SOURCE NHS Human Services
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2

Related medicine news :

1. EUSA Pharma Out-Licenses Preclinical-Stage Human Antibody to GlaxoSmithKline for up to $44 Million Plus Royalties
2. New study shows extent of harmful human influences on global ecosystems
3. Veterinary researchers study poultry virus as human cancer treatment
4. UCLA stem cell scientists reprogram human skin cells into embryonic stem cells
5. Scientists Reprogram Human Skin Cells Into Embryonic Stem Cells
6. Harnessing Human Energy for Medical Good
7. Transparent fish to make human biology clearer
8. Keystone Human Services Acquires Impact Systems, Inc.
9. Human Resource Executive(R) 6th Annual NY HR Week(TM) to Feature HRO World(TM) Conference & Expo
10. Connection between health of wetlands and humans in focus
11. Globetrotting black rat genes reveal spread of humans and diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)...alth-related Questions for Tonight,s,Presidential ...- WebMD, the leading source of,health information,...ial,candidates, proposed health care policies, loc...t the candidates, stance on health insurance, medi... public health issues., The in-depth coverage is ...
(Date:10/7/2008)...PRNewswire-USNewswire/ -- The Ohio Nurses,Associat...ced today its,final round of endorsed candidates f...o Senate:, SD 26 Karen Gillmor (R) Tiffin, Ohio ...(R) Grove City;, HD 28 Connie Pillich (D) Cincinn...These ONA-endorsed candidates for the Ohio General...
(Date:10/7/2008)...wswire-USNewswire/ -- Kristi Yamaguchi, Olympic,Go... the Stars, has been,named chairperson for the 200...gn in an effort to help raise funds in support of ...e and promote lung health., The American Lung Ass...o conquer Tuberculosis. Today, the Lung Associatio...
(Date:10/7/2008)...ar to more expensive whole-leg color ultrasound, ...lthDay News) -- An older, simpler test to look for...osis, or DVT -- is as effective as a newer, more e...searchers found that 2-point ultrasonography of th...trasound -- was as good at detecting DVT as the ne...
Breaking Medicine News(10 mins):Health News:WebMD Highlights Presidential Candidates' Views on Health Care 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3
...taract surgery is higher in patients who have take...rged prostate.// According to the 3 medical assoc...e American Society of Cataract and Refractive Surg...tion, mentioning the use of drugs like Flomax (tam...
...a seriously ill toddler his vital heart monitor du... child who suffers from a rare heart condition has...ous attitude. Stephen Leckey has also appealed to ...ess crime to return the monitor that is an vital p...
...sotretinoin has been found to have more dangerous ... even though it is an effective medication for the...as Accutane in the US and as Roaccutane in UK, and...own to clear up severe acne and prevent scarring, ...
...ng in Australia has found that many South Australi...ving regular screenings// through pap smears. The ...ring 2001-04 more than the 66 in 1997-2000. In th...e was highest with 15 deaths during the period. Pr...
Other Medicine News:Health News:Alpha-blockers call for modification in cataract surgery 2Health News:Alpha-blockers call for modification in cataract surgery 3Health News:Callous Thieves Rob An Seriously Ill Child Of His Vital Heart Machine 2Health News:Acne Drug Found To Cause More Harm than Good 2
(Date:10/7/2008)...al abstracts highlighting CIMZIA,s long-term benef...e patients presented at American College,of Gastro...e-FirstCall/ -- Data from two studies,presented th...terology,(ACG) Annual Meeting demonstrate that CIM...nti-TNF alpha (Tumor Necrosis Factor alpha) - prov...
(Date:10/7/2008)...d 15 Patient Cohort Enrolled in Stage A of Trial A...With Carboplatin and Paclitaxel -, TUSTIN, Calif....aceuticals, Inc. (Nasdaq: PPHM ), a clinical stag...antibodies for the treatment of cancer and,hepatit...t has completed,enrollment in the first stage of a...
(Date:10/6/2008)... and CHIPPENHAM, England, October 7 /PRNewswire-Fi...Mothers Index: 4565) and Vectura,Group plc ("Vectu...tudies,evaluating the efficacy, safety and tolerab...f the European Respiratory Society (ERS) in Berlin...ronium bromide), a novel,inhaled long-acting musca...
(Date:10/6/2008)...N, Oct. 6 /PRNewswire-USNewswire/ -- "A return to ...e development is without scientific,justification,...al,Alternatives to Laboratory Animals (ATLA). "An ...ine Research" concludes that vaccine responses in,...ans, and that claims of,chimpanzees, critical role...
Breaking Medicine Technology:CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 2CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 3CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 7CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 8CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 9Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 3Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 2NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 3NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 5Research Attributes Lack of HIV/AIDS Vaccine to Use of Chimpanzees 2Some Immature Brain Cells May Promote Tumors 9157 1Some Immature Brain Cells May Promote Tumors 9157 2Start Your Day the Sun Shower 28TM 29 Way 9152 1Start Your Day the Sun Shower 28TM 29 Way 9152 2Warner Chilcott to Present at the 26th Annual JPMorgan Healthcare Conference 9147 1Kiwa Fertilizers Pass Independent Tests 2483 1Kiwa Fertilizers Pass Independent Tests 2483 2Kiwa Fertilizers Pass Independent Tests 2483 3
... MALVERN, Pa.--(BUSINESS WIRE)--Apr 18, 2007 - Gem...preclinical data,from a study of its lead compound...tic leukemia (ALL). The study was discussed in an,...rican Association,for Cancer Research (AACR). Acco...ingle agent activity against ALL blast cells,and ...
...lif. and LOS ANGELES, April 18, 2007,/PRNewswire-F...ata,from two preclinical studies, one identifying ...tylase (HDAC) inhibitor and,another demonstrating ...tyrosine kinase (BTK) inhibitor compounds. The dat...ancer Research (AACR),2007 Annual Meeting being he...
Other Medicine Technology:Gemin X Presents Positive Preclinical Data of GX15-070 in Infant,ALL at AACR Meeting 2Gemin X Presents Positive Preclinical Data of GX15-070 in Infant,ALL at AACR Meeting 3Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 2Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 3Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 4Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 5
... of deflectable curve catheters designed to specif...r patients with small anatomies. Each catheter is ... the finest materials. A unique multi-step process...ion technologies results in the excellent torque a...
... of fixed curve catheters designed to specifically...ents with small anatomies. Each catheter is handcr...inest materials. A unique multi-step process that ...chnologies results in the excellent torque and fle...
4Fr, 5Fr & 6Fr diagnostic electrophysiology catheters with fixed curves.
Inquiry 4Fr, 5Fr and 6Fr diagnostic electrophysiology catheters offer simple, precise distal control with it's patented Easy-Hand steering mechanism.
Medicine Products: